Fibrocell Science, Inc. Net Change in Cash
Fibrocell Science, Inc. reported Net Change in Cash of -$7.66 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2019-11-14
- Fibrocell Science, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$3.11M.
- Fibrocell Science, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2018-03-31 was -$5.22M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month |
|---|---|---|---|
| 2019-09-30 | -$7.66M 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | -$755.00K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | -$3.11M 10-Q · filed 2019-05-15 | ||
| 2018-09-30 | -$1.31M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | -$2.01M 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$5.22M 10-Q · filed 2019-05-15 |